Korea Trade Review (무역학회지)

Korea Trade Research Association (한국무역학회)
권호 표지
DOI QR코드

DOI QR Code

A Study on the Countermeasures Taken By the Korean Healthcare and Life Sciences Industry Regarding U.S. Import Refusals: Focus on the Analysis of FDA Violation Codes

한국 바이오헬스 산업의 미국 수입거부 대응 방안 연구 : FDA 위반코드 분석을 중심으로

  • Received : 2023.06.09
  • Accepted : 2023.06.21
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to find a countermeasure to the U.S. import refusals for the Korean healthcare and life sciences industry. To this end, an analysis of trends during the pandemic was conducted using the KITA Border Rejection Database, which includes information on items and types of import refusals. The reason for rejection was also analyzed according to the FDA violation codes. The degree of countermeasure for import refusals was identified by measuring the unit rejection rate (URR). The results of the analysis showed that the major U.S. import refusals for the Korean healthcare and life sciences industry had expanded from contact lenses to COVID-19 diagnostic kits and drugs after the pandemic broke out. The major reasons for import refusals were non-compliance with the Predicate Device and Drugs Act and non-approval by the FDA for products and facilities. On the other hand, the unit rejection rate (URR) of major items in the Korean healthcare and life sciences industry was measured higher than the industry average. The results therefore showed a low level of response to U.S. import refusals. The results of the analysis of reasons for import refusals by item according to FDA violation codes were as follows. First of all, the main violation for contact lenses and COVID-19 diagnostic kits corresponded to misbranding. This was often due to the fact that Korean companies did not provide the relevant notices and information required by the FDA. Many cases also failed to demonstrate a substantial equivalency compared to predicate devices already on the market. On the other hand, applications for new unapproved drugs were not accepted as they had yet to pass relevant regulations that would prove their safety and efficacy. In conclusion, import refusals for the Korean healthcare and life sciences industry were found to be closely related to technical barriers to trade (TBT).

본 연구는 한국 바이오헬스 산업에 대한 미국의 수입거부(Import Refusals) 대응 방안 모색을 목적으로 한다. 이를 위해 수입거부 품목과 유형에 대한 정보가 포함된 한국무역협회 통관거부사례 데이터베이스를 활용하여 팬데믹 시기의 동향 분석을 시행하였으며, FDA 위반코드(Violation Code)에 따라 거부사유까지 분석하였다. 추가적으로 단위거부율(URR)의 측정을 통해 수입거부 대응 수준도 파악하였다. 분석 결과, 한국 바이오헬스 산업에 대한 미국의 주요 수입거부 품목은 과거 콘택트렌즈에서 코로나-19 이후 진단키트와 의약품으로 확대된 것으로 나타났으며, 주요 수입거부 사유는 의료기기와 의약품 관련법의 규정 미준수와 제품 및 시설에 대한 FDA의 미승인으로 확인되었다. 한편 바이오헬스 주요 품목의 단위거부율은 산업 평균보다 높게 측정되어 미국 수입거부 대응 수준이 낮은 것으로 파악되었다. 또한 FDA 위반코드에 따라 품목별 수입거부 사유를 분석한 결과는 다음과 같다. 우선, 콘택트렌즈와 코로나바이러스 진단키트의 주요 위반사항은 부정표시(Misbranding)에 해당한다. 이는 FDA에 관련 통지나 정보가 규정대로 제공되지 않았거나, 시판 중인 기승인 의료기기(Predicate Device)와 비교하여 본질적 동등성을 입증하지 못한 경우가 많다. 반면, 의약품은 유효성 및 안전성 입증 관련 규정에 따라 신청서의 승인을 받지 못한 미승인 신약(Unapproved New Drug)에 해당한다. 결과적으로 바이오헬스 산업의 수입거부는 무역기술장벽(TBT)과 밀접한 관련이 있다.

Keywords

References

  1. 이평.김학민(2019), "미국의 대 아세안 수산물 수입거부조치 파급효과 연구" 「무역학회지」 제44권 제2호, pp.109-126. https://doi.org/10.22659/KTRA.2019.44.2.109
  2. 장용준(2017), "해외 TBT와 SPS의 한국 수출에 대한 효과 분석: 수출비용효과와 수요증진효과" 「한국공공관리학보」 제31권 제3호, pp.319-343. https://doi.org/10.24210/KAPM.2017.31.3.014
  3. 한국무역협회(KITA) 통합무역정보서비스 통관거부사례, (검색일 : 2023년 6월 10일), http://tradenavi.or.kr/CmsWeb/viewPage.req?idx=PG0000001711
  4. 한국무역협회(KITA) 무역통계 품목 수출입 국가별, (검색일 : 2023년 6월 10일), https://stat.kita.net/stat/kts/pum/ItemImpExpList.screen
  5. "2022년 연간 및 12월 수출입 동향" 「산업통상자원부」 2023. 1. 1.
  6. Ahn, J. W. and Rhodes, M. T. (2021), "Examining Pathogen-Based Import Refusals: Trends and Analysis From 2002 to 2019" USDA ERS Economic Information Bulletin, No. 232
  7. Baylis, K., Martens, A. and Nogueira, L. (2009), "What Drives Import Refusals & quest", American Journal of Agricultural Economics, Vol. 91 No. 5, pp. 1477-1483. https://doi.org/10.1111/j.1467-8276.2009.01368.x
  8. Baylis, K., Nogueira, L. and Pace. K. (2010), "Food Import Refusals: Evidence from the European Union", American Journal of Agricultural Economics, Vol. 93 No. 2, pp. 566-572. https://doi.org/10.1093/ajae/aaq149
  9. Bovay, J. (2016), "FDA Refusals of Imported Food Products by Country and Category, 2005-2013" USDA ERS Economic Information Bulletin, No. 151
  10. Buzby, J. C., Unnevehr, L. J. and Roberts, D. (2008), "Food Safety and Imports: An Analysis of FDA Food-Related Import Refusal Reports" USDA ERS Economic Information Bulletin, No. 39
  11. Buzby, J. C. and Regmi, A. (2009) FDA Refusals of Food Imports by Exporting Country Group, Choices, Vol. 24, No. 2, pp. 11-15
  12. Buzby, J. C. and Roberts, D. (2010), "Food Trade and Food Safety Violations: What Can We Learn From Import Refusal Data?" American Journal of Agricultural Economics, Vol. 93, No. 2, pp. 560-565 https://doi.org/10.1093/ajae/aaq148
  13. Geetha, R. et al. (2020), "Trends, causes, and indices of import rejections in international shrimp trade with special reference to India: a 15-year longitudinal analysis", Aquaculture International, No. 28, pp. 1341-1369
  14. Grundke, R. and Moser, C. (2019) "Hidden Protectionism? Evidence from Non-Tariff barriers to trade in the United States" Journal of International Economics, Vol. 117, pp. 143-157 https://doi.org/10.1016/j.jinteco.2018.12.007
  15. Henson, S. and Olale, E. (2011) "What do Border Rejections tell us about Trade Standards Compliance of Developing Countries? Analysis of EU and US Data 2002-2008", UNIDO Working Paper.
  16. Herman, P., Horowitz, J. and Torsekar, M. (2018), "Competitive Conditions Affecting U.S. Expor ts of Medical Technology to Key Emerging Markets", USITC Working Paper, No. 2018-08-A.
  17. Johnson, C. and Sykes, H. (2007), "Medical Devices and Equipment: Competitive Conditions Affecting U.S. Trade in Japan and Other Principal Foreign Markets.", USITC Publication, No. 3909, pp. 332-474.
  18. Jouanjean, M. A. (2012), "Standards, Reputation, and Trade: Evidence from US Horticultural Import Refusals", World Trade Review, No. 11(3), pp. 438-461. https://doi.org/10.1017/S1474745612000274
  19. Kareem, F. O., Brummer, B. and Martinez-Zarzosoc, I. (2015), "Food Safety Standards, Compliance and European Union's Rejection of African Exports: The role of Domestic Factors", GlobalFood Discussion Papers, No. 74
  20. Nguyen, L., Robert, N. and Norbert, W. (2015), "Triggering Factors for US Import Refusals", AgEconSearch SAEA conference paper.
  21. Traore, O. Z., Latouche, K. and Tamini L. D. (2020), "European's RASFF Border Rejections, African Countries's Reputation and Exports of Edible Vegetables and Fruits", CREATE Working Paper, No. 2020-5
  22. U.S. Food and Drug Administration(FDA) Import Refusals (2022. 11. 17.), Available at https://www.fda.gov/industry/fda-import-process/import-refusals
  23. U.S. Federal Food, Drug, and Cosmetic(FD&C) Act, Retrieved June 10, 2023, from http://uscode.house.gov/browse/prelim@title21/chapter9/subchapter5&edition=prelim
  24. U.S. 21 of the Code of Federal Regulations(CFR), Retrieved June 10, 2023, from http://uscode.house.gov/browse/prelim@title21&edition=prelim